163 related articles for article (PubMed ID: 36972566)
21. A randomized study comparing the efficacy of bevacizumab and ranibizumab as pre-treatment for pars plana vitrectomy in proliferative diabetic retinopathy.
Pakzad-Vaezi K; Albiani DA; Kirker AW; Merkur AB; Kertes PJ; Eng KT; Fallah N; Forooghian F
Ophthalmic Surg Lasers Imaging Retina; 2014; 45(6):521-4. PubMed ID: 25423631
[TBL] [Abstract][Full Text] [Related]
22. Network meta-analysis of intravitreal conbercept as an adjuvant to vitrectomy for proliferative diabetic retinopathy.
Wang W; Qu C; Yan H
Front Endocrinol (Lausanne); 2023; 14():1098165. PubMed ID: 36896181
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor concentration in vitreous humor of patients with severe proliferative diabetic retinopathy after intravitreal injection of conbercept as an adjunctive therapy for vitrectomy.
Li B; Li MD; Ye JJ; Chen Z; Guo ZJ; Di Y
Chin Med J (Engl); 2020 Mar; 133(6):664-669. PubMed ID: 32068603
[TBL] [Abstract][Full Text] [Related]
24. The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy.
Ahn J; Woo SJ; Chung H; Park KH
Ophthalmology; 2011 Nov; 118(11):2218-26. PubMed ID: 21724263
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Intravitreal Ranibizumab on the Surgical Outcome for Diabetic Retinopathy With Tractional Retinal Detachment.
Dong F; Yu C; Ding H; Shen L; Lou D
Medicine (Baltimore); 2016 Feb; 95(8):e2731. PubMed ID: 26937902
[TBL] [Abstract][Full Text] [Related]
26. Reoperation following vitrectomy for diabetic vitreous hemorrhage with versus without preoperative intravitreal bevacizumab.
Hu X; Pan Q; Zheng J; Song Z; Zhang Z
BMC Ophthalmol; 2019 Sep; 19(1):200. PubMed ID: 31519158
[TBL] [Abstract][Full Text] [Related]
27. The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study.
Jiang T; Gu J; Zhang P; Chen W; Chang Q
BMC Ophthalmol; 2020 Feb; 20(1):43. PubMed ID: 32013913
[TBL] [Abstract][Full Text] [Related]
28. Intraocular pharmacokinetics of anti-vascular endothelial growth factor agents by intraoperative subretinal versus intravitreal injection in silicone oil-filled eyes of proliferative diabetic retinopathy: a randomized controlled pilot study.
Yao TT; Yang Y; Jin XL; Wang YX; Zhou YL; Xu AJ; He FL; Wang ZY
Acta Ophthalmol; 2020 Nov; 98(7):e795-e800. PubMed ID: 32114709
[TBL] [Abstract][Full Text] [Related]
29. Anti-angiogenic drugs as an adjunctive therapy in the surgical treatment of diabetic retinopathy.
Figueroa MS; Contreras I; Noval S
Curr Diabetes Rev; 2009 Feb; 5(1):52-6. PubMed ID: 19199899
[TBL] [Abstract][Full Text] [Related]
30. Risk Factors of Neovascular Glaucoma After 25-gauge Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study.
Takayama K; Someya H; Yokoyama H; Takamura Y; Morioka M; Sameshima S; Ueda T; Kitano S; Tashiro M; Sugimoto M; Kondo M; Sakamoto T; Takeuchi M
Sci Rep; 2019 Oct; 9(1):14858. PubMed ID: 31619708
[TBL] [Abstract][Full Text] [Related]
31. Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.
Diabetic Retinopathy Clinical Research Network*
JAMA Ophthalmol; 2013 Mar; 131(3):283-93. PubMed ID: 23370902
[TBL] [Abstract][Full Text] [Related]
32. Outcomes and complications of 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.
Ozone D; Hirano Y; Ueda J; Yasukawa T; Yoshida M; Ogura Y
Ophthalmologica; 2011; 226(2):76-80. PubMed ID: 21613797
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of preoperative bevacizumab in diabetics with nonclearing vitreous hemorrhage without tractional detachment - A quasi-randomized retrospective study.
Chakraborty D; Maiti A; Kelkar A; Sengupta S; Roy S; Bolisetty M; Kothari A; Majumder J
Indian J Ophthalmol; 2021 Nov; 69(11):3283-3287. PubMed ID: 34708788
[TBL] [Abstract][Full Text] [Related]
34. Level of Vascular Endothelial Growth Factor in the Vitreous Fluid of Proliferative Diabetic Retinopathy Patients and Prognosis after Vitrectomy.
Suzuki Y; Suzuki K; Kudo T; Metoki T; Nakazawa M
Ophthalmologica; 2016; 236(3):133-138. PubMed ID: 27794575
[TBL] [Abstract][Full Text] [Related]
35. Intravitreal conbercept as an adjuvant in vitrectomy for proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials.
Chen GH; Tzekov R; Mao SH; Tong YH; Jiang FZ; Li WS
Eye (Lond); 2022 Mar; 36(3):619-626. PubMed ID: 33824510
[TBL] [Abstract][Full Text] [Related]
36. Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study.
Park DH; Shin JP; Kim SY
Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):641-50. PubMed ID: 20012643
[TBL] [Abstract][Full Text] [Related]
37. Comparison of before versus after intravitreal bevacizumab injection, growth factor levels and fibrotic markers in vitreous samples from patients with proliferative diabetic retinopathy.
Ozer F; Tokuc EO; Albayrak MGB; Akpinar G; Kasap M; Karabas VL
Graefes Arch Clin Exp Ophthalmol; 2022 Jun; 260(6):1899-1906. PubMed ID: 35028761
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of bevacizumab for vitreous haemorrhage in proliferative diabetic retinopathy with prior complete panretinal photocoagulation.
Park YJ; Ahn J; Kim TW; Park SJ; Joo K; Park KH; Shin JY
Eye (Lond); 2021 Nov; 35(11):3056-3063. PubMed ID: 33420422
[TBL] [Abstract][Full Text] [Related]
39. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.
Martinez-Zapata MJ; Salvador I; Martí-Carvajal AJ; Pijoan JI; Cordero JA; Ponomarev D; Kernohan A; Solà I; Virgili G
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD008721. PubMed ID: 36939655
[TBL] [Abstract][Full Text] [Related]
40. Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial.
Li S; Guo L; Zhou P; Tang J; Wang Z; Zhang L; Zhao M; Qu J
Eye Vis (Lond); 2022 Dec; 9(1):44. PubMed ID: 36451252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
